Table 1. Patient Characteristics.
Clinical and pathologic characteristics of the patient cohort.
| n | 1002 | |
| Age, Median (range) | 61.0 (13.0–91.0) | |
| Stage | ||
| I | 89 | 9.9% |
| II | 91 | 10.1% |
| IIIA/B | 35 | 3.9% |
| IIIC | 565 | 62.8% |
| IV | 119 | 13.2% |
| Grade | ||
| 1 | 81 | 8.4% |
| 2 | 133 | 13.7% |
| 3 | 754 | 77.9% |
| Histology | ||
| Serous | 676 | 67.5% |
| Other | 62 | 6.2% |
| Mixed Cell | 56 | 5.6% |
| Endometrioid | 45 | 4.5% |
| Non-epithelial | 43 | 4.3% |
| Clear Cell | 43 | 4.3% |
| Mucinous | 40 | 4.0% |
| Unknown | 37 | 3.7% |
| Debulking | ||
| Optimal | 604 | 69.8% |
| Suboptimal | 261 | 30.2% |
| Response to Therapy | ||
| Complete Response | 397 | 50.4% |
| Partial Response | 8 | 1.0% |
| Persistent/Stable Disease | 199 | 25.3% |
| Progressive Disease | 31 | 3.9% |
| Death on treatment | 152 | 19.3% |
| Unevaluated | 215 | 21.5% |
| Progression-free survival, median Months | 23.7 (21.9–25.5) | |
| Overall survival, median months | 47.5 (44.4–51.7) | |
| Survival after relapse, median months | 31.1 (28.2–33.5) | |
Clinical and pathologic characteristics of the patient cohort.